Navigation Links
Quintiles Appoints New Executives
Date:6/19/2008

RESEARCH TRIANGLE PARK, N.C., June 19 /PRNewswire/ -- Quintiles Transnational Corp. today named Millie Tan to Senior Vice President, Global Marketing and Chief Marketing Officer and David Coman to the position of Senior Vice President, Communications and Patient Recruitment.

"Both Dave and Millie bring a wealth of experience and impressive records of success in marketing and communication," said Mike Mortimer, Chief Administrative Officer. "I am excited to have them join our senior management team to play key roles in our efforts to strengthen our presence in the marketplace."

Millie joins Quintiles from Monster Worldwide, the global online employment solutions provider, monster.com . Most recently, she was Chief Marketing Officer of its European business, prior to which, she led core marketing in the US. Previously, Millie held increasingly senior positions in consumer marketing with Polaroid and Gillette, including overseas assignments in Hong Kong and Tokyo. She earned her bachelor's degree from Skidmore College in Saratoga Springs, NY, and her master's degree at Columbia University, followed by an MBA at Dartmouth College.

David joins Quintiles from Dendrite International where he was the VP of Global Marketing and led both Marketing and Corporate Communications. Previously, David held executive leadership positions in high-growth telecommunications companies where he initiated groundbreaking direct-to-consumer strategies. He began his career with Young & Rubicam, a market-leading global advertising agency. He earned his bachelor's degree at Michigan State and his MBA from Northwestern University.

About Quintiles

Quintiles Transnational Corp. is powering the next generation of healthcare by providing a broad range of professional services in drug development, financial partnering and commercialization for the biotechnology and healthcare industries. With more than 21,000 employees and offices in more than 50 countries, i
'/>"/>

SOURCE Quintiles Transnational Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Quintiles Appoints Christopher Cabell to Chief Medical and Scientific Officer
2. Quintiles Signs Agreement to Acquire Eidetics
3. Quintiles Consulting Business Expands
4. Quintiles Completes Previously Announced New Investor Partnership, Co-Led by Founder, Chairman and CEO Dennis Gillings, Bain Capital, TPG and 3i
5. Quintiles to Open Clinical Research Office in Wilmington, NC
6. Quintiles Central Lab, Clinical Development in China to Expand, Relocate to New Facility
7. Quintiles Names Kelly McKee Executive Director of Operations for Public Health and Government Services Unit
8. Expert Cardiologist Joins Quintiles Medical Group
9. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
10. EntreMed Appoints Thomas H. Bliss as Senior Vice President of Corporate and Business Development
11. Lentigen Appoints Jim Meade as Vice President of Corporate Development

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...STAD, The Netherlands, December 2 ...ology company focusing on protein mimicking,techno...ay announced that it,has appointed Wim E.M. Mol, P.... Mol will be responsible for all of Pepscans corp...ategic direction of the company. He brings to,Peps...
(Date:12/2/2009)...NJING, China, Dec. 2 /PRNewswire-Asia/ -- Simcere ...(NYSE: SCR ), a leading pharmaceutical company,s... marketing of branded,generic and proprietary phar...its drugs have been included in China,s National D...by China,s Ministry of Human Resources and Social,...
(Date:12/1/2009)... Dr. Kerry Solomon announced that he has joine... redesigned website at www.DrKerrySolomon.com , w...r. Solomon is a proven LASIK, lens implant, and ca...recognized for his substantial contributions to im... of Trusted LASIK Surgeons, which screens LASIK su...
(Date:12/1/2009)... Mass., Dec. 1 Harvest Technologie...sults from the company sponsored 60-patient clinic...er in Chennai, India using the company,s BMAC Syst...ical Limb Ischemia (CLI). Sri Ramachandra Medical ...ed institution based in Chennai, India and one of ...
Breaking Biology Technology:Dutch Biotech Company Pepscan Appoints New CEO 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3
.... 10 In a major victory for its client,Applera Co...ologies, Weil,Gotshal & Manges LLP won a summary j...fe sciences patents. In the action, Enzo Biochem, ...agents and instruments infringed,the patents in qu...le Janet Bond Arterton of the,United States Distri...
...trate that NKTR-118 Shows Promise for the Treatmen...ction, SAN CARLOS, Calif., Sept. 10 Nektar,Thera...t the American College,of Clinical Pharmacology co... 1 trial of NKTR-118 (oral PEG-naloxol). NKTR-118 ...for opioid bowel dysfunction (OBD),including opioi...
...r in Sept. 9 Issue of the Journal Nature Medicine,...th,devastating effects in people with normal chole...s who smoke, or have multiple risk factors. A new,... suffers a heart attack,and yet another doesn,t. ...Institute have,discovered a mechanism that contrib...
Other Biology Technology:Weil Gotshal Wins Major Victory for Applera; Secures Summary Judgment Invalidating Three Patents 2Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting 2Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting 3Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting 4Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting 5Cleveland Clinic-Led Research Uncovers New Mechanism That Heightens Risk of Heart Disease 2Cleveland Clinic-Led Research Uncovers New Mechanism That Heightens Risk of Heart Disease 3
(Date:12/2/2009)... beef, peanut butter, and other foods have done mo...ood safety. They also are quietly fueling a boom i...ing new food safety regulations. That,s the topic ...f Chemical & Engineering News , (C&EN) ACS, weekl...Kemsley and Senior Correspondent Marc Reisch point...
(Date:12/2/2009)...e fit have a higher IQ and are more likely to go o... out at the Sahlgrenska Academy and Sahlgrenska Un...today in the prestigious Proceedings of the Natio...ved 1.2 million Swedish men doing military service... group analysed the results of both physical and I...
(Date:12/2/2009)...porting the first identification of substances inv...hanges harmless marine bacteria into killers that ...S, Environmental Science & Technology , a semi-mo... that bleaching already has destroyed up to 30 per...e searching for ways to slow or stop the damage. O...
Breaking Biology News(10 mins):Young adults who exercise get higher IQ 2American College of Cardiology American Heart Association Comment on the FDA Public Health Advisory Regarding a Drug Interaction Between Clopidogrel a 61574 1American College of Cardiology American Heart Association Comment on the FDA Public Health Advisory Regarding a Drug Interaction Between Clopidogrel a 61574 2Merriman Curhan Ford Acted as Lead Placement Agent in PolyMedixs 2420 7 Million Equity Financing 14880 1Merriman Curhan Ford Acted as Lead Placement Agent in PolyMedixs 2420 7 Million Equity Financing 14880 2Emdeon to Present at the Piper Jaffray Annual Health Care Conference 6359 1
... between the body, mind and spirit has been the su...20 years. The notion that psychosocial and societa... and preventing disease became crystallized as a r...ns. In the 1970s, Cousins, then a writer and magaz...gnosed with an autoimmune disease. He theorized th...
...2009 / b3c newswire / - Addressing signi...e human diagnostics market, InVitria has announced...inant albumin products. InVitria’s Recombina...ee) perform better in diagnostics applications tha...ed human serum albumin (pHSA).  , , The a...
...sease (AD) is a tragic disease that robs an indivi...ight people over the age of 65 now suffer from the...ed with the disease. Contrary to popular belief, A...ial Alzheimer,s disease (FAD), an offshoot of the ...udy , Alzheimer,s is a complex disease, and so to...
Other Biology News:Laughter remains good medicine 2Laughter remains good medicine 3InVitria Announces Launch of Recombinant Albumin for Diagnostics 2Computational model examines the pathways of Alzheimer's that strikes at the young 2
Mouse Anti-TGF-beta 2 Monoclonal Antibody, Unconjugated, Clone 8607 from R&D Systems
Rabbit Anti-ABIN-2 Polyclonal Antibody, Unconjugated from BioVision
Goat Anti-CLIM-2 (T-16) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Rabbit Anti-MD-2 (IN) Polyclonal Antibody, Unconjugated from AnaSpec
Biology Products: